Kent Nilsson, MD
Clinical Cardiac Electrophysiology · Athens, GANPI 1619965381
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $139,883 of the $198,276 with a category attached, or 70.5%. Abbott accounts for 79.4% of it on its own, with 31 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 549 payments — averaging $361.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$157K
- Biosense Webster, Inc.$18K
- Cortex, Inc.$12K
- Altathera Pharmaceuticals LLC$3K
- Boston Scientific$3K
- Medtronic$2K
- plus $3K from 26 others
Across 179 payments — averaging $6832.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$621K
- Cortex, Inc.$234K
- Boston Scientific$151K
- Ablacon, Inc.$123K
- Janssen Research & Development, LLC$65K
- Atricure, Inc.$19K
- plus $11K from 1 others
What the payments were for
- Consulting fees$139,88371%
- Speaking & faculty fees$14,9118%
- Travel & lodging$27,11914%
- Food & beverage$16,2528%
- Gifts$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 304 | $157,486 |
| Biosense Webster, Inc. | 27 | $18,264 |
| Cortex, Inc. | 2 | $11,673 |
| Altathera Pharmaceuticals LLC | 5 | $2,894 |
| Boston Scientific | 43 | $2,765 |
| Medtronic(2 entities) | 21 | $1,936 |
| Cardiva Medical, Inc. | 11 | $504 |
| Amgen | 27 | $426 |
| Novartis | 22 | $380 |
| Atricure, Inc. | 6 | $366 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $291 |
| Johnson & Johnson(2 entities) | 12 | $205 |
| Ablacon, Inc. | 2 | $161 |
| Shockwave Medical, Inc | 7 | $143 |
| AstraZeneca | 6 | $102 |
| Vektor Medical Inc. | 1 | $101 |
| Irhythm Technologies, Inc. | 5 | $72 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Chiesi USA, Inc. | 4 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Pfizer | 3 | $48 |
| Merck | 3 | $48 |
| Boehringer Ingelheim | 3 | $45 |
| Bayer | 2 | $32 |
| Cvrx, Inc. | 2 | $29 |
| Angiodynamics, Inc. | 1 | $27 |
| Abiomed | 1 | $22 |
| Cordis US CORP. | 1 | $19 |
| B. Braun Interventional Systems Inc. | 1 | $18 |
| Volta Medical Inc | 1 | $16 |
| Novo Nordisk | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$71,732
- ALLURE$20,234
- Ensite Cardiac Mapping System$10,699
- Carto 3$10,686
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$8,577
- ENSITE$8,028
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$5,009
- ACCENT$3,881
- ADVISOR$3,589
- Sotalol Hydrochloride$2,894
- Advisor Catheter$1,673
- TactiCath Quartz CFA Catheter$1,649
- ENSITE PRECISION$1,374
- AMPLATZER Occluders$1,077
- EVERA MRI XT DR SURESCAN$969
- Arctic Front$401
- Fortify Assura, Ellipse ICD$223
- Merlin Connectivity and Remote$223
- Quadra Allure MP RF CRT Pacemkr$163
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$161
How this compares
$198,276 in reported general payments places this provider in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 856 | $986,371 |
| XareltoRivaroxaban | 279 | $331,248 |
| Dofetilide | 268 | $49,577 |
| MultaqDronedarone Hcl | 17 | $34,380 |
| EntrestoSacubitril/Valsartan | 28 | $34,237 |
| FarxigaDapagliflozin Propanediol | 11 | $16,847 |
| JardianceEmpagliflozin | 13 | $14,322 |
| Potassium Chloride | 200 | $8,059 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 244 | $7,890 |
| Flecainide Acetate | 88 | $4,635 |
| Metoprolol Succinate | 255 | $4,259 |
| Amiodarone Hcl | 158 | $3,802 |
| Mexiletine Hcl | 27 | $3,771 |
| SotalolSotalol Hcl | 94 | $1,781 |
| Hydralazine Hcl | 75 | $1,747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $48 | $986,371856 claims |
| Johnson & JohnsonXarelto | $205 | $331,248279 claims |
| Sanofi-aventis U.S. LLCMultaq | $58 | $34,38017 claims |
| NovartisEntresto | $380 | $34,23728 claims |
| AstraZenecaFarxiga | $102 | $16,84711 claims |
| Boehringer IngelheimJardiance | $45 | $14,32213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Athens
- Antonio SotolongoAthens$22K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Alok GambhirGainesville$146K
- Joseph PokuMacon$130K
- Anand KeniaDalton$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.